Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > P Mark Colonnese > Profile

P Mark Colonnese

Affiliations

  • Director at Bio-Path Holdings Inc (BPTH), 2019-04-02
  • Chief Financial Officer at Aviragen Therapeutics Inc. (AVIR), 2017-04-05
  • Chief Financial Officer at Transgenomic Inc (TBIO.OB), 2014-02-20
  • Officer at Atherogenics Inc (AGIX), 2009-02-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Biota Pharmaceuticals Inc.
 BOTA $1.41 6,700 Officer 7,000 2016-02-09 Filing
Biota Pharmaceuticals Inc.
 BOTA $1.40 300 Officer 300 2016-02-09 Filing